Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 trial update for a Shigella Sonnei vaccine in healthy adults, assessing efficacy, safety, and immunogenicity; study completed with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysentery Bacillary

Drugs mentioned

• Shigella Sonnei vaccine (GlaxoSmithKline)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dysentery, Bacillary | Phase 2 | Status: COMPLETED | Results posted: 2020-05-15